Gliosarcoma
📧 Sign up to get email alerts when something new happens for Gliosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma [Phase 2]
A Phase 2 study of Palbociclib (PD-0332991) in recurrent RB-positive glioblastoma was terminated. Results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 [Phase 1]
Phase I trial evaluating intratumoral GRm13Z40-2 T-cell therapy (genetically modified allogeneic CD8+ T cells expressing IL-13-Zetakine and …
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
Clinical trial evaluating sorafenib tosylate in combination with temsirolimus in adults with recurrent glioblastoma and gliosarcoma has comp…
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM [Phase 2]
Phase 2 trial evaluating carboxyamidotriazole with radiation therapy for newly diagnosed supratentorial glioblastoma and related tumors has …
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme [Phase 1]
A Phase 1 study evaluating cilengitide in combination with sunitinib malate in adults with advanced solid tumors or glioblastoma multiforme …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma [Phase 1]
Phase 1 study evaluating the combination of cediranib with cilengitide in adults with progressive or recurrent glioblastoma; the trial has c…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 1]
Phase 1 trial evaluating the combination of tipifarnib, temozolomide, and radiation therapy in newly diagnosed glioblastoma multiforme or gl…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating Zactima with Temodar during radiation for newly diagnosed stage IV brain tumors (glioblastoma multifor…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas [Phase 1]
This report covers a Phase I trial of nanoliposomal irinotecan (NL-CPT-11) in patients with recurrent high-grade gliomas, completed to evalu…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 trial update evaluating dasatinib in patients with recurrent glioblastoma multiforme or gliosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated the combination of RO4929097, a gamma-secretase inhibitor, with Cediranib maleate in adults with advanced solid…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
This Phase 1 trial update reports on the combination of tipifarnib, radiation therapy, and temozolomide in adults with newly diagnosed gliob…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma [Phase 1]
Phase 1 trial evaluating high-dose vorinostat with fractionated SBRT in patients with recurrent glioma; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma [Phase 2]
This is a Phase 2 trial update for AR-67 in adults with recurrent glioblastoma multiforme or gliosarcoma. The current status of the study is…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma [Phase 2]
Phase 2 trial evaluating bevacizumab plus temozolomide (Temodar) and erlotinib (Tarceva) in glioblastoma and gliosarcoma; the study is compl…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Sorafenib in Newly Diagnosed High Grade Glioma [Phase 1]
Phase 1 trial update evaluating sorafenib in newly diagnosed high-grade glioma, including glioblastoma, gliosarcoma, and various anaplastic …
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 trial evaluating Gliadel wafers with radiation therapy and temozolomide, with bevacizumab, for newly diagnosed glioblastoma multifor…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma [Phase 1]
A Phase 1 safety study evaluating cabozantinib (XL184) in combination with temozolomide and radiation for newly diagnosed glioblastoma has c…
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: BIBF 1120 for Recurrent High-Grade Gliomas [Phase 2]
Phase 2 trial update on BIBF 1120 (nintedanib) for recurrent high-grade gliomas, with the study status now completed and results posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM [Phase 1]
A Phase I trial evaluating a 5-day regimen of temozolomide plus O6-benzylguanine in patients with recurrent or progressive glioblastoma and …
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Ph I Dasatinib + Erlotinib in Recurrent MG [Phase 1]
Duke University conducted a Phase 1 trial evaluating the combination of dasatinib and erlotinib in recurrent malignant glioma, including gli…
-
CLINICAL_TRIALS withdrawal · 2014-06-02Clinical Trial Update: Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas [Phase 1]
Phase 1 trial evaluating genetically modified stem cells with Irinotecan hydrochloride for recurrent high-grade gliomas has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma [Phase 1]
Phase 1 clinical trial assessing aflibercept in combination with radiation therapy and temozolomide in adults with newly diagnosed or recurr…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 1]
This update covers a Phase 1 trial of sorafenib in patients with recurrent or progressive malignant glioma, including several glioma subtype…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma [Phase 3]
A Phase 3 trial evaluating radiation therapy with temozolomide for newly diagnosed glioblastoma or gliosarcoma has completed with results po…